Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.85B | 2.09B | 2.05B | 2.04B | 1.24B | 1.14B |
Gross Profit | 975.20M | 1.00B | 1.00B | 1.06B | 808.40M | 743.00M |
EBITDA | -89.20M | -158.70M | 236.70M | 355.20M | 310.30M | 293.30M |
Net Income | -459.20M | -304.90M | 81.50M | 143.50M | 229.60M | 240.30M |
Balance Sheet | ||||||
Total Assets | 2.40B | 2.63B | 3.04B | 3.21B | 1.89B | 1.71B |
Cash, Cash Equivalents and Short-Term Investments | 149.60M | 177.60M | 163.00M | 202.90M | 745.30M | 641.45M |
Total Debt | 642.20M | 846.10M | 970.00M | 1.03B | 32.70M | 34.35M |
Total Liabilities | 1.36B | 1.57B | 1.68B | 1.87B | 336.80M | 304.91M |
Stockholders Equity | 1.04B | 1.05B | 1.36B | 1.34B | 1.55B | 1.41B |
Cash Flow | ||||||
Free Cash Flow | 148.40M | 176.40M | 6.40M | -26.80M | 229.82M | 131.01M |
Operating Cash Flow | 176.60M | 196.40M | 94.10M | 29.50M | 264.75M | 210.96M |
Investing Cash Flow | -28.50M | -51.20M | -81.20M | -1.06B | -37.53M | -82.79M |
Financing Cash Flow | -95.80M | -125.60M | -57.10M | 520.30M | -122.40M | -54.31M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $5.37B | 45.77 | 8.60% | ― | 10.14% | 0.04% | |
75 Outperform | $14.82B | 27.48 | 11.38% | ― | 1.28% | -17.73% | |
73 Outperform | $5.70B | 29.67 | 4.36% | 1.05% | 1.11% | -23.73% | |
71 Outperform | $9.12B | 23.32 | 15.36% | 1.30% | 1.51% | 21.70% | |
68 Neutral | $2.61B | 16.51 | 18.27% | ― | 0.91% | 45.81% | |
54 Neutral | $7.48B | 116.65 | -20.54% | ― | -8.36% | -669.36% | |
51 Neutral | $7.91B | -0.36 | -41.71% | 2.23% | 23.45% | -1.86% |
On August 18, 2025, William Jellison resigned from the Board of Directors of Masimo Corporation, with no disagreements cited regarding company operations. The Chairman of the Board, Michelle Brennan, expressed gratitude for his contributions during a transformative period for the company.
On August 5, 2025, Masimo Corporation announced its financial results for the second quarter of 2025, reporting a GAAP revenue of $371 million, an 8% growth, and a non-GAAP revenue of $370 million, a 7% growth on a constant currency basis. The company’s non-GAAP net income per diluted share grew by 46% compared to the previous year. CEO Katie Szyman highlighted the company’s strong performance and strategic focus on expanding its leadership in pulse oximetry and implementing effective tariff mitigation measures, which have positively impacted its growth strategy and market position.
Masimo Corporation has made strategic leadership changes to enhance its commercial operations, appointing Tim Benner as Chief Marketing and Strategy Officer, Huimin Wang as President of Japan & Asia Pacific, and Lisa Hellmann as Chief Human Resources Officer in 2025. Additionally, Micah Young has expanded his role to include corporate development. The company is also seeking a Chief Commercial Officer. Meanwhile, Chief Operating Officer Bilal Muhsin announced his resignation effective July 1, 2025, and the company will not fill the COO role immediately.
Masimo Corporation plans to engage with investors to reaffirm its financial outlook for fiscal 2025, as initially provided on May 6, 2025. The company is addressing a cybersecurity incident that may impact its operations, with potential legal, reputational, and financial risks, as well as possible regulatory inquiries and business disruptions.